These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

915 related items for PubMed ID: 22704876

  • 1. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging.
    Fuernau G, Zaehringer S, Eitel I, de Waha S, Droppa M, Desch S, Schuler G, Adams V, Thiele H.
    Int J Cardiol; 2013 Sep 01; 167(5):2134-9. PubMed ID: 22704876
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance and relationship of worst lead residual ST segment elevation with myocardial damage assessed by cardiovascular MRI in myocardial infarction.
    Rommel KP, Baum A, Mende M, Desch S, Gutberlet M, Schuler G, Thiele H, Eitel I.
    Heart; 2014 Aug 01; 100(16):1257-63. PubMed ID: 25049315
    [Abstract] [Full Text] [Related]

  • 3. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O, Breuckmann F, Jensen C, Jochims M, Naber CK, Barkhausen J, Erbel R, Sabin GV, Herzinfarktverbund Essen.
    Herz; 2008 Mar 01; 33(2):136-42. PubMed ID: 18344033
    [Abstract] [Full Text] [Related]

  • 4. Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction.
    Çanga A, Durakoğlugil ME, Erdoğan T, Kirbaş A, Yilmaz A, Çiçek Y, Ergül E, Çetin M, Kocaman SA.
    J Cardiol; 2012 Nov 01; 60(5):355-60. PubMed ID: 22727437
    [Abstract] [Full Text] [Related]

  • 5. High osteoprotegerin levels predict MACCE in STEMI patients, but are not associated with myocardial salvage.
    Bjerre M, Munk K, Sloth AD, Nielsen SS, Flyvbjerg A, Bøtker HE.
    Scand Cardiovasc J; 2014 Aug 01; 48(4):209-15. PubMed ID: 24758546
    [Abstract] [Full Text] [Related]

  • 6. Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Pedersen S, Mogelvang R, Bjerre M, Frystyk J, Flyvbjerg A, Galatius S, Sørensen TB, Iversen A, Hvelplund A, Jensen JS.
    Cardiology; 2012 Aug 01; 123(1):31-8. PubMed ID: 22964478
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular magnetic resonance-derived intramyocardial hemorrhage after STEMI: Influence on long-term prognosis, adverse left ventricular remodeling and relationship with microvascular obstruction.
    Husser O, Monmeneu JV, Sanchis J, Nunez J, Lopez-Lereu MP, Bonanad C, Chaustre F, Gomez C, Bosch MJ, Hinarejos R, Chorro FJ, Riegger GA, Llacer A, Bodi V.
    Int J Cardiol; 2013 Sep 01; 167(5):2047-54. PubMed ID: 22682700
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction.
    Eitel I, de Waha S, Wöhrle J, Fuernau G, Lurz P, Pauschinger M, Desch S, Schuler G, Thiele H.
    J Am Coll Cardiol; 2014 Sep 23; 64(12):1217-26. PubMed ID: 25236513
    [Abstract] [Full Text] [Related]

  • 9. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G, Pica S, Raineri C, Bramucci E, De Ferrari GM, Klersy C, Ferlini M, Marinoni B, Repetto A, Romeo M, Rosti V, Massa M, Raisaro A, Leonardi S, Rubartelli P, Oltrona Visconti L, Ferrario M.
    JACC Cardiovasc Interv; 2013 Oct 23; 6(10):1055-63. PubMed ID: 24156966
    [Abstract] [Full Text] [Related]

  • 10. ST-segment depression resolution predicts infarct size and reperfusion injury in ST-elevation myocardial infarction.
    Reinstadler SJ, Baum A, Rommel KP, Eitel C, Desch S, Mende M, Metzler B, Poess J, Thiele H, Eitel I.
    Heart; 2015 Nov 23; 101(22):1819-25. PubMed ID: 26385452
    [Abstract] [Full Text] [Related]

  • 11. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
    Ezekowitz JA, Armstrong PW, Granger CB, Theroux P, Stebbins A, Kim RJ, Patel MR.
    Am Heart J; 2010 Aug 23; 160(2):272-8. PubMed ID: 20691832
    [Abstract] [Full Text] [Related]

  • 12. Osteoprotegerin levels change during STEMI and reflect cardiac function.
    Lindberg S, Jensen JS, Hoffmann S, Iversen AZ, Pedersen SH, Mogelvang R, Galatius S, Flyvbjerg A, Bjerre M.
    Can J Cardiol; 2014 Dec 23; 30(12):1523-8. PubMed ID: 25475457
    [Abstract] [Full Text] [Related]

  • 13. Distal protection device aggravated microvascular obstruction evaluated by cardiac MR after primary percutaneous intervention for ST-elevation myocardial infarction.
    Yoon CH, Chung WY, Suh JW, Cho YS, Youn TJ, Chun EJ, Choi SI, Chae IH, Choi DJ.
    Int J Cardiol; 2013 Sep 01; 167(5):2002-7. PubMed ID: 22633663
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cytochrome c release in acute myocardial infarction predicts poor prognosis and myocardial reperfusion on contrast-enhanced magnetic resonance imaging.
    Liu ZB, Fu XH, Wei G, Gao JL.
    Coron Artery Dis; 2014 Jan 01; 25(1):66-72. PubMed ID: 24077325
    [Abstract] [Full Text] [Related]

  • 16. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.
    Eitel I, Wöhrle J, Suenkel H, Meissner J, Kerber S, Lauer B, Pauschinger M, Birkemeyer R, Axthelm C, Zimmermann R, Neuhaus P, Brosteanu O, de Waha S, Desch S, Gutberlet M, Schuler G, Thiele H.
    J Am Coll Cardiol; 2013 Apr 02; 61(13):1447-54. PubMed ID: 23466078
    [Abstract] [Full Text] [Related]

  • 17. Association of smoking with myocardial injury and clinical outcome in patients undergoing mechanical reperfusion for ST-elevation myocardial infarction.
    Reinstadler SJ, Eitel C, Fuernau G, de Waha S, Desch S, Mende M, Metzler B, Schuler G, Thiele H, Eitel I.
    Eur Heart J Cardiovasc Imaging; 2017 Jan 02; 18(1):39-45. PubMed ID: 26976354
    [Abstract] [Full Text] [Related]

  • 18. Effect of Pericardial Effusion Complicating ST-Elevation Myocardial Infarction as Predictor of Extensive Myocardial Damage and Prognosis.
    Jobs A, Eitel C, Pöss J, Desch S, Thiele H, Eitel I.
    Am J Cardiol; 2015 Oct 01; 116(7):1010-6. PubMed ID: 26235929
    [Abstract] [Full Text] [Related]

  • 19. Impact of infarct location and size on clinical outcome after ST-elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Reindl M, Holzknecht M, Tiller C, Lechner I, Schiestl M, Simma F, Pamminger M, Henninger B, Mayr A, Klug G, Bauer A, Metzler B, Reinstadler SJ.
    Int J Cardiol; 2020 Feb 15; 301():14-20. PubMed ID: 31761400
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction.
    Eitel I, Kubusch K, Strohm O, Desch S, Mikami Y, de Waha S, Gutberlet M, Schuler G, Friedrich MG, Thiele H.
    Circ Cardiovasc Imaging; 2011 Jul 15; 4(4):354-62. PubMed ID: 21518773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.